# MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)

> **NCT03026998** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut Curie** · enrollment: 88 (actual)

## Conditions studied

- Hereditary Retinoblastoma

## Interventions

- **PROCEDURE:** MRI

## Key facts

- **NCT ID:** NCT03026998
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-03-19
- **Primary completion:** 2034-03
- **Final completion:** 2034-03
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03026998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03026998, "MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03026998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*